EC Status and Availability

Congo, Democratic Republic (Kinshasa)

EC ever use among women of reproductive age: 1.1% (DHS 2007)

EC knowledge among women of reproductive age: 18.8% (DHS 2013-14)

Contraceptive Use: 19.4% (DHS 2007, ever use of any modern method among women of reproductive age)

Registered LNG-EC products:

Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.

Where at least one type of ECP is available: Public sector clinics, Pharmacies, IPPF-affiliated system

Age restrictions for accessing ECPs: No data available

Legal/regulatory documents in which EC is included: Essential Medicines List

Pricing information: In Kinshasa, the median price of LNG EC in the public sector is $1.43 and the median price of LNG EC in the private sector is $1.21, as of September 2016. In Katanga, the median price of LNG EC in the public and private sectors is $3.30, as of September 2016.

Other relevant information: EC distributed via IPPF outlets (1,000 - 5,000 in 2012).

1% of married contraceptive users and 4% of unmarried sexually active contraceptive users used EC in 2014 in the DRC according to PMA2020 data.

EC is not included in the National Strategic Plan for Family Planning (2014-2020).

For more information, see below:

Our country-by-country information comes from numerous sources, including partners from around the world. We have made every effort to ensure that the information included here is correct, but EC availability and policies can change quickly. We welcome your additions and/or corrections

To submit updates and corrections to ICEC, click here.

Begin a new search